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Abstract:  
Abyssinones and related flavonoids were screened against 3 enzymes (3βHSD, 17βHSD and Aromatase) of steroidogenesis 
pathway. The virtual screening experiment shows high affinity for flavonones than their respective chalcones.  A 4’ –OH 
blocked prenylated flavonone 2b (2-(2’, 2’-dimethyl chroman-6’-yl)-7-hydroxy chroman-4-one) had consistent binding 
affinity to all the three enzymes used in this study showing higher binding affinity to aromatase.  A good correlation was 
observed between cytotoxic data (MCF-7, breast cancer cell line) and docking results indicating flavonone as a better 
steroidogenesis modulator in hormone dependent cancer. 
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Background: 
Cancer is one of the major causes of death across the 
world. It is largely controllable disease and highly 
susceptible to modulation by dietary factors.   
Epidemiologic evidence suggests an association between 
the consumption of fruits and vegetables with reduced 
incidence of cancer [1, 2]. Over the years, numerous 
bioactive compounds have been identified that contribute 
to these beneficial health effects. Polyphenols are the most 
abundant antioxidants in human diet and are widespread 
constituents of fruits, vegetables, cereals and in beverages 
such as tea, coffee and wine. Polyphenols are gaining 
importance because of their various biological activities 
such as anti-cancer [3], anti-viral [4], anti-inflammatory 
[5], anti-ulcer [6] and anti-fungal [7] along with their anti-
oxidant properties. As antioxidants, polyphenols may 
protect cell constituents against oxidative damage. 
Therefore, they can limit the risk of various degenerative 
diseases associated with oxidative stress, such as 
cardiovascular diseases, diabetes and cancer [2, 8]. In 
complex biological systems, polyphenols exhibit several 
additional properties which may be independent of 
conventional antioxidant activities leading to novel 
mechanism of interacting with cell signaling and 
modulating several cell activities [9 10].   
 
Flavonoids are polyphenolic compounds which are 
fundamental components of the human diet present as 
constituents of flowering plants, particularly of food plants. 
They are phenyl substituted chromones (benzopyran 
derivatives) consisting of a 15-carbon basic skeleton (C6-
C3-C6). Several plants and spices containing flavonoid 
derivatives have found application as disease preventive 
and therapeutic agents in traditional medicine in Asia for 
thousands of years [11]. Epidemiological investigations 
and human clinical trials indicate that flavonoids have 
important effects on cancer chemoprevention and 
chemotherapy. Many mechanisms of action such as 
antiproliferation, cell cycle arrest, induction of apoptosis 
and differentiation, inhibition of angiogenesis, reduction of 
oxidative damage and reversal of multidrug resistance or a 
combination of these mechanisms have been identified 
[12]. Most of the biological activities are attributed to 
substitution of prenyl and hydroxyl groups present in the 
flavonoid ring system [13].  
 
Breast cancer is the leading cause of cancer in women 
worldwide, both in the developed and developing 
countries. The breast cancer ranked second after cervix in 
the developing countries [14]. It is well established that 
estrogen modulates cell function. Studies have shown that 
cell proliferation in breast cancer depends on levels of 
estrogen and estrogen receptors especially in hormone 
dependent breast cancer [15]. Hence the enzymes involved 
in synthesis and regulation of estrogen becomes important 
targets for breast cancer therapy. In steroidogenesis, 
estrogen is synthesized from cholesterol as starting 
molecule to androstenedione, a compound with androgenic 
activity and finally converted into estrodiol or estrone by 
regulation of three important enzymes, 3 βHSD, 17 βHSD 
and Aromatase. Amongst all, aromatase - an enzyme of the 
cytochrome  P450 family is a very well considered and 
important pharmacological target, particularly for the 
treatment of breast cancer [16]. Natural polyphenolic 
compounds such as flavones, flavonones, resveratrol, and 
oleuropein are shown to be strong aromatase inhibitors 
[17], but inhibit to a lesser extent the other two enzymes 
3βHSD and 17βHSD [18, 19].  Abyssinones are prenylated 
flavonoids isolated from plant Erythrina abyssinica. These 
molecules have gained attention since abyssinone II [20] 
reported to show aromatase inhibitory activity. We have 
recently synthesized Abyssinone-I (2a), abyssinone-II (2c) 
and related compounds and studied their anti-oxidant 
properties [21]. 
 
In the present study, we have screened a set of flavonones 
and their respective chalcones (Figure 1) including 
abyssinones for the cytotoxic effect in MCF-7 (breast 
cancer) cell line. As these flavonoids are reported to be 
effective aromatase inhibitors, docking studies were 
carried out to screen potent molecules with high cytotoxic 
effect as well as a good inhibition for the 3 βHSD 
(E.C.1.1.1.145), 17 βHSD (E.C.1.1.1.62) and/or aromatase 
(E.C.1.14.14.1) enzymes, since aromatase inhibitors are 
target for new drug synthesis to treat hormone-dependent 
cancers, in addition to breast cancer [22]. Bioinformation by Biomedical Informatics Publishing Group                    open access 
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Figure 1: Compounds under study. 
 
Methodology: 
Chemicals: 
MTT [3-(4, 5- dimethyl-thiazol-2-yl)-2, 5-diphenyl -2H- 
tetrazolium bromide], Dimethyl sulfoxide, DMEM (D-
5648) medium from Sigma-Aldrich, Heat inactivated 
serum from Gibco BRL, Antibiotic & antimycotic solution 
and other chemicals were purchased from Himedia, India. 
 
Cell culture: 
MCF-7 human breast carcinoma cell line (Purchased from 
NCCS, Pune, India) was maintained in DMEM medium 
supplemented with 10% FBS and antibiotics solution at 
37
0C in ambient air with 5% CO2. The sub culturing was 
done every 2-3 days. The flavonoids were dissolved in 
dimethyl sulfoxide with serial dilution ranging from 
2.5μM-100μM. MTT assay: Quantification of cell viability 
was performed using the cleavage of MTT to a blue 
colored complex (formazan), which is indicator for 
mitochondrial succinate dehydrogenase activity in viable 
cells  [23]. Cells were seeded in 96 well plates, 
supplemented with flavonoids of different concentration 
and incubated for 24 hrs. After incubation 20 μl of 5 mg/ml 
MTT dissolved in PBS was added to culture well and 
further incubated for 4 hrs at 37
0C. Supernatants were 
removed and 200 μl of DMSO was added to each well. The 
optical density was measured at 580 nm with molecular 
Devices ELISA reader. Dose response curve were plotted 
after converting the mean values in to percentages of 
control response. Flavonoid doses resulting in 50% 
inhibition of live cells were derived from plotted data.  
 
In-silco analysis: 
Preparation of proteins 
The Comparative Modeled structure of cytochrome P450 
aromatase (Pdb code: 1TQA), modeled structure of 3 
βHSD [24] and crystal structure of 17 βHSD (Pdb code: 
1FDT) was considered for docking studies.  All the protein 
structures were prepared for docking by adding polar 
hydrogen, except haem all hetero atoms removed and all 
the bonds set as rigid using MGLTools 1.5.1. 
 
Preparation of ligands  
All the ligands were drawn; geometrically optimized using 
ACD/ChemSketch 10.0 and energy minimized using The 
Dundee PRODRG2 Server [25]. All the maximum allowed 
torsions in the ligands were set as flexible. 
 
Docking studies using AutoDock 4.0 
Using MGLTools 1.5.1, a grid spacing of 0.374 Å with 
126x126x126 points for all the proteins were prepared. 
Docking for 100 number of GA runs was carried out using 
Lamarckian Genetic Algorithm (LGA) and all other 
parameters set to default. The top ranked model in the 
lowest energy cluster with maximum cluster size was 
considered for all further interaction studies. 
 
Discussion: 
It is already known that flavonoids are steroidogenesis 
modulators [18] and also have been widely exploited as 
inhibitors of aromatase which is a regulatory enzyme in the 
synthesis of estrogen [17]. Out of ten prenylated 
compounds screened for cytotoxic activity in MCF cell-
line, compound 1c showed the lowest IC50, 2e being least 
cytotoxic, while rest showed IC50 values varying from 60 
to 70 μM (Figure 2). Chalcones had higher cytotoxic 
effect and their binding affinity with steriodogenic 
enzymes was less when compared to flavonones.  Though, 
1c had good cytotoxic effect, its binding affinity for 
steroidogenesis enzymes considered in the present study 
was least. Different substitutants on flavonones influence 
the binding affinity of the compounds to the enzymes. 
Presence of prenyl group in flavonone enhances its binding 
affinity to 3 βHSD and 17 βHSD while there was minimal 
influence on aromatase binding.   
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Figure 2: Graph plot of Binding energies of all the compounds with their respective IC50 values. 
 
Aromatase: 
Though natural ligand, androstenedione did not show any 
H-bonds in our docking studies, it showed electrostatic 
interactions with Val370.  Whereas, 7-hydroxy in 
flavonones forms H-bonds with Val370 showing 
competitive affinity to the same amino acid over natural 
ligand.  The present study reveals that, flavonones with 
protected 4’ hydroxyl showed better aromatase inhibitory 
activity than their free hydroxyl analogs irrespective of the 
presence of prenyl groups.  Present docking data matches 
well with the aromatase inhibitory assay results reported by 
Moriaty et al [26]. 
 
3 βHSD: 
Our study showed that, 3, 17 hydroxyls of androstenediol 
forms hydrogen bonds with Ser221 and Ile192 
respectively.  We have also observed that in case of 
Abyssinone I (2a) and its analog (2b) carbonyl and oxygen 
in 4’ position formed hydrogen bonds with Arg198 and 
Ser221 respectively.  As Ser221 forms hydrogen bond in 
both the cases, the interaction might be contributing factor 
to the binding affinity of the compounds.  The common 
electrostatic interactions found between the enzyme and 
flavonones 2a, 2b and natural ligand are Val223, Tyr193, 
Lys219, Phe199, Ile192, Ser221, Asn318 and Tyr191.  
 
17 βHSD: 
We found that, 3-hydroxy of Estrone formed hydrogen 
bond with Glu194.  Whereas, in case of 2a and 2b 7-
hydroxy and 4-carbonyl formed hydrogen bond with 
Gly144 and Val188 respectively.  Ser142, Pro187, Val188, 
Phe226 and Gly186 amino acids of the enzyme were 
commonly interacting with 2a, 2b and natural ligand 
considered.  
 
Conclusion: 
Steroidogenesis enzymes (aromatase, 17βHSD and 
3βHSD) which are potential target of hormone dependent 
cancer were considered for docking and screening studies. 
This work finds application using these targets to design 
drugs for the treatment of hormone dependent cancer.  The 
competitive binding efficiency of enzyme targets with 
prenylated and non-prenylated flavanoids confers them as 
steroidogenic modulator. Consequently, the approach is 
useful in designing novel molecules for treatment of 
hormone dependent cancer.  
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